HLS Therapeutics Inc.
HLTRF
Price:
$2.34
Market Cap:
$74.40M
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular (CV) markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsules; and PERSERIS, an injectable risperidone product for the treatment of schizophrenia. It also offers MyCare psychiatry lab assays and MyCare Insite point of care therapeutic drug-level monitoring tests. In addition, the company holds the U.S. marketing rights of Absorica, a commercial stage dermatology product; ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-01-27
Stock Exchange
PNK
Ticker
HLTRF
The Current Ratio as of September 2024 (TTM) for HLS Therapeutics Inc. (HLTRF) is 2.02
According to HLS Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.02. This represents a change of 16.47% compared to the average of 1.74 of the last 4 quarters.
HLS Therapeutics Inc. (HLTRF) Historical Current Ratio (quarterly & annually)
How has HLTRF Current Ratio performed in the past?
The mean historical Current Ratio of HLS Therapeutics Inc. over the last ten years is 12.95. The current 2.02 Current Ratio has changed 1.46% with respect to the historical average. Over the past ten years (40 quarters), HLTRF's Current Ratio was at its highest in in the March 2016 quarter at 88.28. The Current Ratio was at its lowest in in the March 2019 quarter at 0.79.
Average
12.95
Median
1.62
Minimum
0.83
Maximum
58.64
HLS Therapeutics Inc. (HLTRF) Current Ratio by Quarter and Year
Discovering the peaks and valleys of HLS Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.21%
Maximum Annual Current Ratio = 58.64
Minimum Annual Increase = -96.67%
Minimum Annual Current Ratio = 0.83
| Year | Current Ratio | Change |
|---|---|---|
| 2023 | 1.65 | 16.13% |
| 2022 | 1.42 | -10.02% |
| 2021 | 1.58 | 22.74% |
| 2020 | 1.29 | -3.77% |
| 2019 | 1.34 | 62.01% |
| 2018 | 0.83 | -56.04% |
| 2017 | 1.88 | -96.67% |
| 2016 | 56.38 | -3.86% |
| 2015 | 58.64 | 1.21% |
| 2014 | 4.46 | 24.46% |
HLS Therapeutics Inc. (HLTRF) Average Current Ratio
How has HLTRF Current Ratio performed in the past?
The current Current Ratio of HLS Therapeutics Inc. (HLTRF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
1.55
5-year avg
1.46
10-year avg
12.95
HLS Therapeutics Inc. (HLTRF) Current Ratio vs. Peers
How is HLTRF’s Current Ratio compared to its peers?
HLS Therapeutics Inc.’s Current Ratio is greater than Aion Therapeutic Inc. (0.18), less than Cipher Pharmaceuticals Inc. (11.18), less than Cannara Biotech Inc. (2.32), less than Knight Therapeutics Inc. (3.41), greater than Canntab Therapeutics Limited (0.57), greater than Bionoid Pharma Inc. (0.34), less than Crescita Therapeutics Inc. (3.37), greater than CENTR Brands Corp. (0.08), less than RAMM Pharma Corp. (0), greater than Craftport Cannabis Corp. (0.03), greater than Speakeasy Cannabis Club Ltd. (1.40), greater than City View Green Holdings Inc. (0.01), greater than RavenQuest BioMed Inc. (1.14), greater than Lowell Farms Inc. (1.14),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.18 | $2.80M | |
| 11.18 | $292.48M | |
| 2.32 | $43.59M | |
| 3.41 | $459.62M | |
| 0.57 | $147.02K | |
| 0.34 | $9.75M | |
| 3.37 | $407.02K | |
| 0.08 | $1.86M | |
| 0 | $15.16M | |
| 0.03 | $2.01M | |
| 1.40 | $1.31K | |
| 0.01 | $1.42M | |
| 1.14 | $482.11K | |
| 1.14 | $627.26K |
Build a custom stock screener for HLS Therapeutics Inc. (HLTRF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HLS Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
HLS Therapeutics Inc. (HLTRF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like HLS Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is HLS Therapeutics Inc.'s Current Ratio?
How is the Current Ratio calculated for HLS Therapeutics Inc. (HLTRF)?
What is the highest Current Ratio for HLS Therapeutics Inc. (HLTRF)?
What is the 3-year average Current Ratio for HLS Therapeutics Inc. (HLTRF)?
What is the 5-year average Current Ratio for HLS Therapeutics Inc. (HLTRF)?
How does the current Current Ratio for HLS Therapeutics Inc. (HLTRF) compare to its historical average?